OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study
Jeremiah Tan, Sasha Bernatsky, Jennifer L. Lee, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 104-104
Open Access
Jeremiah Tan, Sasha Bernatsky, Jennifer L. Lee, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 104-104
Open Access
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 22
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 22
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
Serena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8525-8525
Open Access | Times Cited: 10
Immune Response to COVID-19 Vaccination in Frontline Healthcare Workers
Birutė Strukčinskienė, Zydre Valotkiene, Jonas Jurgaitis, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 199-199
Open Access | Times Cited: 3
Birutė Strukčinskienė, Zydre Valotkiene, Jonas Jurgaitis, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 199-199
Open Access | Times Cited: 3
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
Tonino Alonzi, Alessandra Aiello, Michela Sali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117153-117153
Open Access | Times Cited: 3
Tonino Alonzi, Alessandra Aiello, Michela Sali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117153-117153
Open Access | Times Cited: 3
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
Annapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1247-1247
Open Access | Times Cited: 8
Annapaola Santoro, Andrea Capri, Daniele Petrone, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1247-1247
Open Access | Times Cited: 8
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
S. Garcia-Cirera, Joan Calvet, Juan Francisco Delgado de la Poza, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
Rhys T. Meredith, Max D. Bermingham, Kirsten Bentley, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Rhys T. Meredith, Max D. Bermingham, Kirsten Bentley, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS‐CoV ‐2 booster vaccination in hematologic neoplasms
Moraima Jiménez, Candela Fernández‐Naval, Vı́ctor Navarro, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1204-1213
Closed Access | Times Cited: 6
Moraima Jiménez, Candela Fernández‐Naval, Vı́ctor Navarro, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1204-1213
Closed Access | Times Cited: 6
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies
Samuel D. Klebanoff, Lauren B. Rodda, Chihiro Morishima, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 5
Samuel D. Klebanoff, Lauren B. Rodda, Chihiro Morishima, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 5
Spike protein is a key target for stronger and more persistent T-cell responses—a study of mild and asymptomatic SARS-CoV-2 infection
Ivan Ssali, Susan Mugaba, Arthur Kalyebi Watelo, et al.
International Journal of Infectious Diseases (2023) Vol. 136, pp. 49-56
Open Access | Times Cited: 5
Ivan Ssali, Susan Mugaba, Arthur Kalyebi Watelo, et al.
International Journal of Infectious Diseases (2023) Vol. 136, pp. 49-56
Open Access | Times Cited: 5
Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls
Dóra Németh, Hajnalka Vágó, László Tóthfalusi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Dóra Németh, Hajnalka Vágó, László Tóthfalusi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
Saeid Najafi Fard, Chiara Farroni, Linda Petrone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Saeid Najafi Fard, Chiara Farroni, Linda Petrone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis
Jenna M. Benoit, Jessica A. Breznik, Jann C. Ang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Jenna M. Benoit, Jessica A. Breznik, Jann C. Ang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies
Carolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 6, pp. 757-761
Open Access | Times Cited: 3
Carolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 6, pp. 757-761
Open Access | Times Cited: 3
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine
Holly Dudley, Megan L. O’Mara, Ann Auma, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6112-6119
Open Access | Times Cited: 3
Holly Dudley, Megan L. O’Mara, Ann Auma, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6112-6119
Open Access | Times Cited: 3
The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 620-620
Open Access | Times Cited: 2
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 620-620
Open Access | Times Cited: 2
Attitudes and concerns regarding booster dose of COVID-19 vaccine among Egyptian patients with autoimmune and rheumatic diseases: a cross-sectional survey study
Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Samar Tharwat, Elshimaa Saad Eleraky, Toqa Adel, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study
Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003094-e003094
Open Access | Times Cited: 2
Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003094-e003094
Open Access | Times Cited: 2
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
Serena Vita, Emanuela Giombini, Patrizia De Marco, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024043-e2024043
Open Access
Serena Vita, Emanuela Giombini, Patrizia De Marco, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024043-e2024043
Open Access
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients
María José Gallardo, Marcos Cruces, Yolanda M. Gómez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
María José Gallardo, Marcos Cruces, Yolanda M. Gómez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
